| Day 1 | Day 7 | |||||
---|---|---|---|---|---|---|---|
Characteristics | N | Median | IQR | N | Median | IQR | |
Lowest platelets (*109/L) | Â | Â | Â | Â | Â | Â | |
 | Survivors | 667 | 226 | 159 to 316 | 426 | 267 | 164 to 388 |
 | Non-survivors | 307 | 185 | 113 to 280 | 214 | 146 | 78 to 274 |
Urinary volume (ml/24 hours) | Â | Â | Â | Â | Â | Â | |
 | Survivors | 666 | 1,499 | 916 to 2,170 | 429 | 2460 | 1,680 to 3,633 |
 | Non-survivors | 307 | 1,080 | 475 to 1,915 | 215 | 1750 | 471 to 2,774 |
Highest bilirubin (mmol/L) | Â | Â | Â | Â | Â | Â | |
 | Survivors | 667 | 13 | 8 to 21 | 433 | 9 | 5 to 17 |
 | Non-survivors | 307 | 14 | 8 to 25 | 217 | 14 | 6 to 25 |
GCS SOFA score | Â | Â | Â | Â | Â | Â | |
 | Survivors | 667 | 0 | 0 to 0 | 453 | 0 | 0 to 0 |
 | Non-survivors | 307 | 0 | 0 to 2 | 221 | 1 | 0 to 2 |
Renal SOFA score | Â | Â | Â | Â | Â | Â | |
 | Survivors | 667 | 0 | 0 to 1 | 453 | 0 | 0 to 1 |
 | Non-survivors | 307 | 1 | 0 to 3 | 221 | 1 | 0 to 3 |